Sunitinib in patients with or without prior nephrectomy (Nx) in an expanded access trial of metastatic renal cell carcinoma (mRCC)

被引：9
|
作者：
Szczylik, C.
Porta, C.
Bracarda, S.
Hawkins, R.
Bjarnason, G. A.
Oudard, S.
Lee, S.
Carteni, G.
Hariharan, S.
Gore, M. E.
机构：
[1] Mil Med Inst, Warsaw, Poland
[2] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[3] Azienda Osped Perugia, Perugia, Italy
[4] Christie Hosp, Manchester, Lancs, England
[5] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[6] Hop Europeen Georges Pompidou, Paris, France
[7] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[8] Pfizer Inc, New York, NY USA
[9] Royal Marsden Hosp NHS Trust, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5124
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 453 - 454
  • [32] SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY IN METASTATIC CLEAR CELL CARCINOMA
    Baradaran, Nima
    Drabkin, Harry
    Savage, Stephen
    JOURNAL OF UROLOGY, 2015, 193 (04): : E872 - E872
  • [33] PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC)
    Bex, Axel
    Blank, Christian
    Chowdhury, Simon
    Nichol, David
    Peters, John
    Horenblas, Simon
    O'Brien, Tim
    Sarwar, Naveed
    Haanen, John
    Powles, Thomas
    JOURNAL OF UROLOGY, 2011, 185 (04): : E709 - E710
  • [34] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    M E Gore
    C Szczylik
    C Porta
    S Bracarda
    G A Bjarnason
    S Oudard
    S-H Lee
    J Haanen
    D Castellano
    E Vrdoljak
    P Schöffski
    P Mainwaring
    R E Hawkins
    L Crinò
    T M Kim
    G Carteni
    W E E Eberhardt
    K Zhang
    K Fly
    E Matczak
    M J Lechuga
    S Hariharan
    R Bukowski
    British Journal of Cancer, 2015, 113 : 12 - 19
  • [35] Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
    Gore, M. E.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S-H
    Haanen, J.
    Castellano, D.
    Vrdoljak, E.
    Schoeffski, P.
    Mainwaring, P.
    Hawkins, R. E.
    Crino, L.
    Kim, T. M.
    Carteni, G.
    Eberhardt, W. E. E.
    Zhang, K.
    Fly, K.
    Matczak, E.
    Lechuga, M. J.
    Hariharan, S.
    Bukowski, R.
    BRITISH JOURNAL OF CANCER, 2015, 113 (01) : 12 - 19
  • [36] SUNITINIB AND SORAFENIB THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC): SAFETY PROFILE
    Massari, Francesco
    Cricca, Antonia
    Sperandi, Francesca
    Martoni, Andrea Angelo
    ANTICANCER RESEARCH, 2010, 30 (04) : 1379 - 1380
  • [37] Presurgical sunitinib in primary metastatic renal cell carcinoma (mRCC) - Interim analysis of a prospective trial
    Bex, A.
    Blank, C.
    Horenblas, S.
    Haanen, J.
    BJU INTERNATIONAL, 2010, 105 : 10 - 11
  • [38] Phase I trial of sunitinib (S) and temsirolimus (T) in metastatic renal cell carcinoma (mRCC)
    Campbell, Matthew T.
    Millikan, Randall E.
    Altinmakas, Emre
    Xiao, Lianchun
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [39] TARIBO trial: Targeted therapy with or without nephrectomy in metastatic renal cell carcinoma (mRCC)-Liquid biopsy for biomarkers discovery
    Verzoni, Elena
    Bearz, Alessandra
    Bracarda, Sergio
    Bregni, Marco
    Buti, Sebastiano
    Cinieri, Saverio
    De Giorgi, Ugo
    Fornarini, Giuseppe
    Galli, Luca
    Milella, Michele
    Morelli, Franco
    Nole, Franco
    Passalacqua, Rodolfo
    Sabbatini, Roberto
    Santini, Daniele
    Salvioni, Roberto
    Cappelletti, Vera
    Grassi, Paolo
    De Braud, Filippo G.
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Sunitinib Prior to Planned Cytoreductive Nephrectomy: Is This the New Litmus Test for Metastatic Renal Cell Carcinoma?
    Kim, Simon P.
    Thompson, R. Houston
    EUROPEAN UROLOGY, 2011, 60 (03) : 455 - 456
12345